4 results on '"Garcés, Luis"'
Search Results
2. Protective response mediated by immunization with recombinant proteins in a murine model of toxocariasis and canine infection by Toxocara canis.
- Author
-
Jaramillo-Hernández, Dumar Alexander, Salazar Garcés, Luis Fabián, Pacheco, Luis Gustavo Carvalho, Pinheiro, Carina Silva, and Alcantara-Neves, Neuza Maria
- Subjects
- *
RECOMBINANT proteins , *CANIS , *TOXOCARIASIS , *PROTEIN models , *VACCINE trials - Abstract
• Recombinant proteins obtained by vaccinology reverse protected mice against T. canis. • First recombinant protein vaccine to be clinically tested in canines against T. canis. • Canines presented an immune response and decrease in the excretion of T. canis eggs. • Canine toxocariasis control by recombinant protein vaccine has promising results. Toxocariasis is a neglected parasitic zoonosis of global importance. The development of a formulation that can be used as a vaccine would help the definitive control of the infection. Preclinical studies selected two recombinant T. canis proteins (rTcVcan and rTcCad) which significantly protected mice against larval migration. In the present work, these proteins plus three adjuvants (Alhydrogel®, PAM3CSK4®, and Quil-A®) were used to immunize mice against toxocariasis; blood samples were collected three times to measure IgG (total, IgG1, IgG2a), IgA, and IgE via indirect ELISA. Cytokines (IL-5, TNF-α, and IL-10) were measured in splenocytes supernatant, and T. canis larvae were quantified in tissues. The best protein + adjuvant pair found (rTVcan + QuialA®) was then used to immunize T. canis -free puppies (n = 18) that were experimentally infected with T. canis and T. canis naturally-infected puppies (n = 6). Immunoglobulin (IgA, IgE, IgG, IgG1, and IgG2a), parasite load (eggs in feces), number of expelled adults and eggs extracted from the female uterus, and their fertility percentages were analyzed. In mice, it was observed a highly significant reduction (73%) of tissue larvae, a mixed cytokine profile (Th 1 /Th 2), and anti- T. canis antibody titers (IgG, IgG1, IgG2a) using rTVcan + QuialA® mix. In canines, rTVcan + QuialA® promoted reduction in the parasite eggs in feces (95%) and eggs reduction obtained from the uteri of pharmacologically expelled adult females (58.38%). In our knowledge this is the first canine clinical trial of a vaccine with T. canis recombinant proteins. The formulation used has been shown to efficiently stimulate the production of antibodies against infection by T. canis. In the canine, a significant reduction in the number of eggs expelled by the experimental animals that received the formulation prophylactically was evidenced. Future tests should be developed to evaluate the duration of the protective effect and analyze other immune pathways that could be stimulated by the formulation used. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Direct synthesis of copper faujasite
- Author
-
Hincapie, Beatriz O., Garces, Luis J., Gomez, Sinue, Ghosh, Ruma, and Suib, Steven L.
- Published
- 2005
- Full Text
- View/download PDF
4. Immunogenicity and protection induced by recombinant Toxocara canis proteins in a murine model of toxocariasis.
- Author
-
Salazar Garcés, Luis Fabián, Santiago, Leonardo Freire, Santos, Sara Patrícia de Oliveira, Jaramillo Hernández, Dumar Alexander, da Silva, Marcia Barbosa, Alves, Vitor dos Santos, Silveira, Elisania Fontes, Barrouin-Melo, Stella Maria, Cooper, Philip John, Pacheco, Luis Gustavo Carvalho, Pinheiro, Carina da Silva, and Alcantara-Neves, Neuza Maria
- Subjects
- *
PROTEIN models , *TOXOCARA , *INFECTION control , *HELMINTHIASIS , *CANIS , *RECOMBINANT proteins - Abstract
• In Silico data were used for the selection of T. canis antigens as vaccine candidate. • T. canis recombinant antigens were used effectively for the control of toxocariasis. • The rTcCad and rTcVcan proteins can be an efficient vaccine for the definitive hosts. • Th1/Th2 response showed in this study can be effective in controlling toxocariasis. Toxocariasis, a natural helminth infection of dogs and cats caused by Toxocara canis and T. cati , respectively, that are transmitted to mammals, including humans. Infection control is based currently on periodic antihelmintic treatment and there is a need for the development of vaccines to prevent this infection. Materials and Methods: Eight potential vaccine candidate T. canis recombinant proteins were identified by in silico (rTcGPRs, rTcCad, rTcVcan, rTcCyst) and larval proteomics (rTES26, rTES32, rMUC-3 and rCTL-4) analyses. Immunogenicity and protection against infectious challenge for seven of these antigens were determined in a murine model of toxocariasis. C57BL/6 female mice were immunized with each of or combinations of recombinant antigens prior to challenge with 500 T. canis embryonated eggs. Levels of specific antibodies (IgG, IgG1, IgG2a and IgE) in sera and cytokines (IL-5, INF-ɣ and IL-10) produced by antigens-stimulated splenocytes, were measured. Presence of specific antibodies to the molecules was measured in sera of T. canis -seropositive dogs and humans. Results: All seven molecules were immunogenic in immunized mice; all stimulated significantly elevated levels of specific IgG, IgG1 or IgG2a and six were associated with elevated levels of specific IgE; all induced elevated production of IFN- ɣ and IL-10 by splenocytes, but only the in silico -identified membrane-associated recombinants (rTcCad, rTcVcan, and rTcCyst) induced significantly increased IL-5 production. Vaccination with two of the latter (rTcCad and rTcVcan) reduced larval loads in the T. canis challenged mice by 54.3% and 53.9% (P < 0.0001), respectively, compared to unimmunized controls. All seven recombinants were recognized by T. canis -seropositive dog and human sera. Conclusion: The identification of vaccine targets by in silico analysis was an effective strategy to identify immunogenic T. canis proteins capable of reducing larval burdens following challenge with the parasite. Two recombinant proteins, rTcCad and rTcVcan, were identified as promising vaccine candidates for canine toxocariasis. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.